X0306 4 2018-06-18 0 0000883984 ICU MEDICAL INC/DE ICUI 0001189727 BURCAR ALISON D 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Vice President and Gen'l Mgr. Common Stock 2018-06-18 4 X 0 17108 58.79 A 21311 D Common Stock 2018-06-18 4 S 0 1700 302.93 D 19611 D Common Stock 2018-06-18 4 S 0 1800 304.16 D 17811 D Common Stock 2018-06-18 4 S 0 412 304.73 D 17399 D Common Stock 2018-06-18 4 S 0 100 305.9 D 17299 D Common Stock 2018-06-18 4 S 0 191 305.9 D 17108 D Common Stock 2018-06-18 4 S 0 7199 301.56 D 9909 D Common Stock 2018-06-18 4 S 0 5735 302.75 D 4174 D Common Stock 2018-06-18 4 S 0 1977 303.4 D 2197 D Common Stock 2018-06-18 4 S 0 2197 304.65 D 0 D Common Stock 2018-06-19 4 X 0 34747 58.79 A 34747 D Common Stock 2018-06-19 4 S 0 2500 300.2 D 32247 D Common Stock 2018-06-19 4 S 0 26973 301.84 D 5274 D Common Stock 2018-06-19 4 S 0 5274 302.27 D 0 D Common Stock 2018-06-20 4 X 0 21169 58.79 A 21169 D Common Stock 2018-06-20 4 S 0 5294 300.73 D 15875 D Common Stock 2018-06-20 4 S 0 13750 301.66 D 2125 D Common Stock 2018-06-20 4 S 0 2125 302.5 D 0 D Non-Qualified Stock Option (right to buy) 58.79 2018-06-18 4 X 0 17108 0.0 D 2024-02-24 Common Stock 17108 57892 D Non-Qualified Stock Option (right to buy) 58.79 2018-06-19 4 X 0 34747 0.0 D 2024-02-24 Common Stock 34747 23145 D Non-Qualified Stock Option (right to buy) 58.79 2018-06-20 4 X 0 21169 0.0 D 2024-02-24 Common Stock 21169 1976 D These securities are Restricted Stock Units. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.50 to $303.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.55 to $304.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.60 to $304.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. All shares sold were sold at the exact price disclosed. Shares were previously acquired through the Registrant's Employee Stock Purchase Plan. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.05 to $303.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.10 to $304.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.15 to $305.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.10 to $302.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.13 to $302.40, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.20 to $301.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.30 to $302.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Options exercisable in four equal annual cumulative installments commencing one year after the grant date. Transaction is the exercise of a derivative security; see Column 2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2018. By: Alejandro Parras, Attorney-In-Fact For: Alison Burcar 2018-06-20